Novartis Investigative Site

Pozuelo de Alarcon/Madrid 28223

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Thrombocytopaenia

Studies at this site

• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) — Stopped early